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ABSTRACT: Rod outer segment membrane guanylate cyclase (ROS-GC) transduction system is a central
component of the Ca2+-sensitive phototransduction machinery. The system is composed of two parts:
Ca2+ sensor guanylate cyclase activating protein (GCAP) and ROS-GC. GCAP senses Ca2+ impulses and
inhibits the cyclase. This operational feature of the cyclase is considered to be unique and exclusive in
the phototransduction machinery. A combination of reconstitution, peptide competition, cross-linking,
and immunocytochemical studies has been used in this study to show that the GCAP1/ROS-GC1
transduction system also exists in the photoreceptor synaptic (presynaptic) termini. Thus, the presence of
this system and its linkage is not unique to the phototransduction machinery. A recent study has
demonstrated that the photoreceptor-bipolar synaptic region also contains a Ca2+-stimulated ROS-GC1
transduction system [Duda, T., et al. (2002) EMBO J. 21, 2547-2556]. In this case, S100â senses Ca2+
and stimulates the cyclase. The inhibitory and stimulatory Ca2+-modulated ROS-GC1 sites are distinct.
These findings allow the formation of a new topographic model of ROS-GC1 transduction. In this model,
the catalytic module of ROS-GC1 at its opposite ends is flanked by GCAP1 and S100â modules. GCAP1
senses the Ca2+ impulse and inhibits the catalytic module; S100â senses the impulse and stimulates the
catalytic module. Thus, ROS-GC1 acts as a bimodal Ca2+ signal transduction switch in the photoreceptor
bipolar synapse.
An important conceptual advancement is emerging in the
membrane guanylate cyclase field. It predicts that the rod
outer segment membrane guanylate cyclase (ROS-GC),1 a
subfamily of membrane guanylate cyclases, is the universal
transduction machinery for the Ca2+ impulses arising in the
sensory neurons. According to the cellular environment, Ca2+
either inhibits the machinery or stimulates it (reviewed in
ref 1). The former, and the first operational feature of the
machinery, was established with studies of the photoreceptor
cells in which the initial individual components of the
transduction machinery were discovered (reviewed in refs 2
and 3). ROS-GC, native to PR-OS, the site of phototrans-
duction, was purified (4-7), sequenced in part (7), and then
cloned, based on the sequences of its four peptides (8). Its
functional identity to the native ROS-GC was established
by its Ca2+-dependent reconstitution; it mimicked the native
conditions of phototransduction (9), in which Ca2+ with a
K1/2 of 100 nM inhibits the guanylate cyclase (10, 11). In
these studies, the recombinant form of GCAP1 was used as
a Ca2+ sensor (9). It was, thereby, established that the
GCAP1/ROS-GC1 system is a Ca2+-sensitive component of
the phototransduction machinery. The studies supported an
earlier prediction that a membrane-bound guanylate cyclase
operates by Ca2+ through a Ca2+-binding factor, whose
identity at the time was unknown (12).
Phototransduction is a biochemical process, where the light
signal generates an electrical signal (reviewed in refs 2 and
3). Two interlocked critical components of the process are
Ca2+ and cyclic GMP (12-15). The photon captured by its
receptor rhodopsin creates a decline in the level of cyclic
GMP, which results in closure of the CNG channel, and
hyperpolarization of the photoreceptor plasma membrane.
Closure of CNG-gated channels prevents Ca2+ from entering
the cell, but a continuous operation of a Na+/Ca2+,K+-
exchanger leads to a decrease in the intracellular Ca2+
concentration from 500 nM in the dark-adapted photore-
ceptor cell to <100 nM. This in turn causes the activation
of ROS-GC. An increased level of synthesis of cyclic GMP,
which is concomitant with inactivation of the phototrans-
duction cascade, results in opening of the channel and,
thereby, restoration of the dark current of the photoreceptors.
According to the current knowledge of the phototrans-
duction field, ROS-GC exists in two forms: the original form
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(8), renamed ROS-GC1 [retGC1, GC-E (16, 17)], and ROS-
GC2 (18) [retGC2, GC-F (17, 19)]. To date, the majority of
the biochemical work has been focused on ROS-GC1.
Functional GCAP exists in three forms: GCAP1-GCAP3
(11, 20-22). Reconstitution studies with recombinant ROS-
GC1 indicate that it can sense changes in free Ca2+
concentrations through either of the two GCAPs, 1 or 2 (9,
23, 24). Each GCAP binds with a specific module in ROS-
GC1, residing in the intracellular region of the cyclase (9,
23, 25-27). In the current phototransduction model, GCAPs
and ROS-GC1 form a regulatory unit in native PR-OS
(reviewed in ref 2). GCAPs sense light-dependent Ca2+
fluctuations and, in turn, cause proportionate changes in
ROS-GC1 activity. In this way, three pivotal components
of phototransduction (Ca2+, GCAPs, and ROS-GC1) are
physiologically connected. In the dark phase, the free Ca2+
concentration is 500 nM, Ca2+ is bound to GCAP, and the
cyclase is in its basal state. Increasing levels of photoillu-
mination intensity cause graded decreases in the concentra-
tion of Ca2+. These cause concomitant increases in the
cyclase activity, which, in turn, alter the cyclic GMP
concentration in the photoreceptor cell.
To date, the GCAP-modulated Ca2+-signaling ROS-GC1
transduction system has been established in PR-OS as a sole
constituent of the phototransduction machinery. This study
expands the boundaries of this system. It unequivocally
establishes that the GCAP1/ROS-GC1 transduction system
also exists in the photoreceptor synaptic terminus where, like
in PR-OS, the system is inhibited by Ca2+. Earlier studies
have detected the presence of a ROS-GC, without distin-
guishing between ROS-GC1 and ROS-GC2, in retinal cells
other than photoreceptors, including the synaptic layers (28,
29). Immunolocalization studies have also suggested that
GCAP1 and GCAP2 are present in synaptic regions (30, 31).
A more recent study has shown that the photoreceptor-
bipolar synaptic region also contains the Ca2+-stimulated
ROS-GC1 transduction system (34). The system achieves
the stimulatory feature via its Ca2+ sensor S100â, whose
target sites are specifically mapped to two short regions in
the C-terminal domain of ROS-GC1 (34). These sites are
distinct from the GCAP1-modulated sites (25, 34). On the
basis of the findings that ROS-GC1 attains reciprocal,
bimodal regulation through its defined Ca2+ sensor compo-
nent and the component influences ROS-GC1 through its
specified domain, a new topographic model of the ROS-
GC1 transduction system is proposed. The model contends
that the catalytic module of ROS-GC1 is flanked by GCAP1
and S100â regulatory modules. GCAP1 senses the Ca2+
impulse and inhibits the catalytic module; S100â senses the
impulse and stimulates the catalytic module. Thus, ROS-
GC1 operates as a bimodal Ca2+ signal transduction switch,
both stimulated and inhibited by Ca2+ sparks in the photo-
receptor-bipolar synapse region. Together with similar
earlier findings in the pinealocytes (35) and in the olfactory
system (36, 37), this study suggests the universality and
versatility of the Ca2+-dependent ROS-GC transduction
machinery in sensory neurons. Furthermore, the findings
indicate that the spatial environment and the microdomain
structure of the machinery determine whether Ca2+ waves
accelerate or retard it in the formation of cyclic GMP.
EXPERIMENTAL PROCEDURES
Antibodies. Characterization of highly specific antibodies
raised against ROS-GC1 and GCAP1 has been described
previously (35-37). After the specificity of the reaction had
been established, the ROS-GC1 and GCAP1 antibodies were
enriched by precipitating the immunoglobulin fraction using
ammonium sulfate. The antibodies were finally purified on
antigen-affinity columns. ELISA and Western blots were
used to determine the titer of the enriched antibodies. A
dilution of 1:5000 was generally used for colorimetric
detection of the antigen on Western blots. A monoclonal
antibody against S100â (clone SH-B1) was purchased from
Sigma, and the SV-2 antibody was from DBHSS.
Synthesis of Oligopeptides. The peptides corresponding to
ROS-GC1 regions L503-I522, scrambled 503-522, D507-
R518, and G968-G985 were synthesized as described
previously (25, 38).
Expression Studies. COS-7 cells (simian virus 40-
transformed African green monkey kidney cells), maintained
in Dulbecco’s modified Eagle’s medium with penicillin,
streptomycin, and 10% fetal bovine serum, were transfected
with the wild type-recombinant (wt-r) ROS-GC1 expression
construct by the calcium phosphate coprecipitation technique
(39). Sixty hours after transfection, cells were washed twice
with 50 mM Tris-HCl (pH 7.5) and 10 mM buffer, scraped
into 2 mL of cold buffer, homogenized, centrifuged for 15
min at 5000g, and washed several times with the same buffer.
The resulting pellet represented crude membranes.
Preparation of the Retinal P1 Fraction. The isolation of
the P1 fraction from the bovine retina was carried out
according to the originally published technique (40), and
recently used in the analysis of the outer synaptic (P1) layer
as described in ref 34. The preparation was aliquoted and
stored at -150 °C until it was used.
Guanylate Cyclase ActiVity Assay. Membrane fractions
were assayed for guanylate cyclase activity as described
previously (41). Briefly, membranes were preincubated on
an ice bath with or without GCAP1 or S100â in the assay
system containing 10 mM theophylline, 15 mM phospho-
creatine, 20 íg of creatine kinase, and 50 mM Tris-HCl (pH
7.5) adjusted to the appropriate free Ca2+ concentrations with
precalibrated Ca2+/EGTA solutions (Molecular Probes). The
total assay volume was 25 íL. The reaction was initiated
by addition of the substrate solution containing 4 mM MgCl2
and 1 mM GTP and maintained by incubation at 37 °C for
10 min. The reaction was terminated by addition of 225 íL
of 50 mM sodium acetate buffer (pH 6.2) followed by heating
in a boiling water bath for 3 min. The amount of cyclic GMP
that was formed was determined by a radio-immunoassay
(42).
Peptide Competition Experiments. These were carried out
with both native (PR-OS or P1) and recombinant (expressed
in COS cells) ROS-GC1 (4, 11, 34). Respective membranes
were assayed for guanylate cyclase activity in the presence
of 10 nM Ca2+ and 4 íM GCAP1 with incremental
concentrations of peptides.
Western Blot. Western blotting was carried out according
to the previously published protocols (35, 37). Briefly, the
protein samples were transferred onto nitrocellulose mem-
branes after electrophoresis. The membranes were incuba-
ted in Tris-buffered saline containing 0.05% Tween 20
(TBS-T) and 3% bovine serum albumin (BSA) for 1 h at
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room temperature followed by incubation for 1 h in the same
solution containing the primary antibody. After the mem-
branes had been washed with TBS-T, incubation was
continued for the same period of time in TBS-T containing
3% BSA and the secondary antibody. Then, visualization of
the immunoreactive protein bands was carried out according
to the manufacturer’s (Vector labs) protocol.
Cross-Linking. Cross-linking was carried out with the
imidoester dimethyl suberimidate (DMSâ2HCl) on mem-
branes isolated from the P1 fraction. This noncleavable cross-
linker was chosen because it is water-soluble. One hundred
micrograms of protein (with or without added recombinant
GCAP1) was incubated at room temperature with shaking
for 60 min. The reaction was carried out in 0.2 M trietha-
nolamine (pH 8.0) in the presence of DMS concentrations
ranging from 20 to 0.2 mM. It was terminated by the addition
of Tris-HCl (pH 6.8) to a final concentration of 100 mM,
followed by the addition of SDS-PAGE loading dye.
Samples were analyzed by SDS-PAGE (12 or 7%), followed
by transfer and Western blotting. Duplicates were probed
independently with highly specific antibodies against ROS-
GC1 or GCAP1. Western blotting was carried out as
described previously (35, 37).
Immunohistochemistry. Cryosections of the retina were
prepared and used according to the procedure described
previously (35). Briefly, the retina was fixed for 1 h in 4%
formaldehyde at 4 °C; it was cryoprotected in 25% sucrose
overnight at 4 °C and cut in sections with a thickness of 16
ím (Leica cryostat). To block nonspecific protein binding,
sections were incubated in 0.1 M phosphate buffer containing
10% normal goat serum, 5% sucrose, and 0.5% Triton X-100
for 60 min at room temperature. The sections were then
incubated in the same solution containing primary antibodies
overnight at 4 °C, washed, and incubated with secondary
antibodies conjugated to a fluorescent dye and diluted in the
blocking solution. Washes were carried out at room tem-
perature (three times for 10 min each) with 0.1 M phosphate
buffer containing 5% sucrose. For detection of ROS-GC1
in the synaptic regions, the detergent was omitted from the
buffer. Specimens were mounted using Vectashield mounting
medium. Images were acquired using a confocal microscope
(Leica). Digital images were processed using commercially
available software (ImagePro Plus, Phase3 Imaging Systems
and Adobe Photoshop). Controls included immunostaining
reactions carried out under identical conditions except that
either primary antibody was omitted or was replaced with
preimmune serum. Staining was insignificant in either case.
RESULTS
The P1 Membrane Fraction Contains a Membrane
Guanylate Cyclase, which Exhibits a Biphasic Type of
Ca2+ Modulation
The P1 fraction from the bovine retina, comprising the
outer plexiform layer (OPL), was isolated as described in
Experimental Procedures. Incubation of the P1 membranes
with incremental Ca2+ concentrations showed that the
fraction contained a guanylate cyclase transduction system,
which was either stimulated or inhibited depending on the
free Ca2+ concentration (Figure 1). A range of Ca2+
concentrations from 10 nM to 0.4 íM caused a dose-
dependent decrease in the cyclase activity, while higher Ca2+
concentrations caused a stimulation. The inhibitory value
(IC50) for Ca2+ was 100 nM, and the stimulatory value (EC50)
was 0.8 íM. The identity of the Ca2+-stimulated guanylate
cyclase transduction system in the P1 membrane fraction has
been reported recently (34). It consists of ROS-GC1 and its
Ca2+ sensor component S100â (34). This raised a question
about the identity of the Ca2+-inhibited membrane guanylate
cyclase transduction system. This issue has been addressed
below.
The Ca2+-Inhibitory Transduction Component of the P1
Cyclase Is Represented by GCAP1/ROS-GC1
To determine if the Ca2+-inhibited native P1 cyclase is
similar to the phototransduction-linked ROS-GC, the P1
cyclase was subjected to multiple tests.
Test 1. The PR-OS and the P1 membrane fractions were
isolated, and it was made certain that each does not cross
contaminate the other (34). Side by side, these fractions were
assayed for membrane guanylate cyclase activity in the
presence of incremental Ca2+ concentrations, ranging from
10 nM to 0.7 íM. The results presented in Figure 2 show
that the cyclase activity in both fractions is incrementally
inhibited. The inhibition patterns of the two fractions are
almost identical; the IC50 for Ca2+ in both cases is 100 nM.
Thus, the native P1 and the native PR-OS guanylate cyclases
are functionally indistinguishable.
Test 2. Biochemical and functional similarities between
the two native, P1 and PR-OS, guanylate cyclases were
further established as follows. One sequence motif in ROS-
GC1 that is critical and specific for GCAP1 activation is
between amino acids L503 and I522 (25). The core motif
within this amino acid domain consists of D507-R518. To
assess similarity (or dissimilarity) between the biochemical
mechanisms involved in the functional Ca2+-inhibited gua-
nylate cyclase machineries of the P1 and ROS-GC1 trans-
duction systems, the P1 and PR-OS membrane fractions, side
by side, were incubated with incremental concentrations of
FIGURE 1: Ca2+ regulation of guanylate cyclase activity in
membranes of the photoreceptor-bipolar cell synaptic layer (P1).
The P1 fraction was prepared from the bovine retina as described
in Experimental Procedures. These membranes were assayed for
guanylate cyclase activity in the presence of incremental concentra-
tions of Ca2+. Guanylate cyclase activity in the presence of 10 nM
Ca2+ was 0.9 ( 0.1 nmol of cyclic GMP (mg of protein)-1 min-1.
The experiments were carried out in triplicate and repeated three
times with separate membrane preparations. The results are from
one representative experiment.
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the L503-I522 and D507-R518 peptides at 10 nM Ca2+.
A peptide with the scrambled sequence of L503-I522
constituted a control. The results demonstrated a dose-
dependent inhibition, reaching 65% for the L503-I522
peptide and 83% for the D507-R518 peptide in both the
P1 and PR-OS fractions (Figure 3). The scrambled peptide,
at concentrations of up to 0.25 mM, in both fractions only
minimally (5-15%) inhibited the cyclase; at a concentra-
tion of 0.5 mM, the extent of inhibition was 20-30%
(Figure 3). Furthermore, in both fractions, there was a
reversal of the peptide (D507-R518)-dependent inhibition
when an excess of GCAP1 was added (Figure 3C,D). These
peptide competition and GCAP1 reconstitution results dem-
onstrate that the Ca2+-inhibited modulation of the cyclases
in the P1 and PR-OS membrane fractions occurs by identical
mechanisms, in which the modulation is mediated by GCAP1
and the modulated cyclase in both cases is the same, ROS-
GC1. Hence, the operational biochemical components of the
native P1 and PR-OS cyclase machineries are identical, and
they are represented by GCAP1/ROS-GC1 transduction
systems.
Test 3. The conclusions from test 2 were further confirmed
by reconstitution experiments using recombinant ROS-GC1
and GCAP1. The recombinant ROS-GC1 was expressed in
the heterologous COS cell system. At 50 nM Ca2+, recom-
binant GCAP1 stimulated ROS-GC1 in a dose-dependent
fashion with an EC50 of 1 íM. The maximal stimulation of
the enzyme was achieved at 4 íM GCAP1 (Figure 4A). The
D507-R518 peptide inhibited the cyclase in a concentration-
dependent fashion. The kinetics of inhibition of the recom-
binant ROS-GC1 were nearly identical to those of the cyclase
present in the native P1 and PR-OS membrane fractions
(compare Figure 4B with panels A and B of Figure 3). The
control peptide, with a scrambled D507-R518 sequence,
only very minimally inhibited ROS-GC1. These results
validate the conclusions of test 2 and further show the direct
participation of ROS-GC1 in GCAP1-mediated Ca2+ signal
transduction in the P1 membrane fraction.
Test 4. The aim of this test was to directly establish the
presence of GCAP1 in the P1 membrane fraction. Western
blot analysis of the fraction was performed with the GCAP1-
specific antibody according to a previous protocol (35). It is
noted that this antibody has an absolute specificity for
GCAP1 and does not react with the other member, GCAP2
(Figure 5A, compare rGCAP1 and rGCAP2). Purified
PR-OS membrane preparations (PR-OS lane) and recombi-
FIGURE 2: Effect of Ca2+ on guanylate cyclase activity in the P1
fraction and comparison with the effect of Ca2+ on the ROS-GC
system present in the membrane fraction of photoreceptor outer
segments. Membrane fractions from the P1 synaptosomal fraction
(P1) and photoreceptor outer segments (PR-OS) were isolated as
described in Experimental Procedures. These membranes were
assayed for guanylate cyclase activity in the presence of incremental
concentrations of Ca2+. Guanylate cyclase activities in the presence
of 10 nM Ca2+ were 0.9 ( 0.1 nmol of cyclic GMP (mg of
protein)-1 min-1 for the P1 fraction and 9.0 ( 0.5 nmol of cyclic
GMP (mg of protein)-1 min-1 for the PR-OS fraction. The
experiments were carried out in triplicate and repeated three times
with separate membrane preparations. The results are from one
representative experiment.
FIGURE 3: Effect of synthetic peptides derived from the ROS-GC1
sequence on GCAP1-dependent stimulation of ROS-GC1 activity.
Membranes of P1 (A) or PR-OS (B) fractions were reconstituted
with 2 íM GCAP1 and 10 nM Ca2+ and incubated with the
indicated peptide concentrations. Membranes of P1 (C) or PR-OS
(D) fractions were incubated with 2 íM GCAP1 and 250 íM
D507-R518 peptide at 10 nM Ca2+ with or without the indicated
concentrations of GCAP1. The experiment was carried out in
triplicate and repeated three times for reproducibility. The results
are from one typical experiment. Error bars are within the size of
the symbols.
FIGURE 4: Dose-dependent response of recombinant ROS-GC1 to
GCAP1 and the effect of synthetic D507-R518 and scrambled
D507-R518 peptides. Membranes of COS cells expressing ROS-
GC1 were used. (A) They were reconstituted with the indicated
concentrations of GCAP1 and 10 nM Ca2+. (B) They were
incubated with 2 íM GCAP1 and increasing concentrations of either
peptide at 10 nM Ca2+. Experiments were carried out in triplicate
and repeated at least two times for reproducibility. The data are
from a representative experiment.
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nant GCAP1 (rGCAP1 lane) served as positive controls. A
single 21 kDa GCAP1 immunoreactive band, indicated with
an arrow, with identical mobility was detected in each case
(Figure 5B, compare rGCAP1, PR-OS, and P1). Thus, the
native P1 fraction contains GCAP1.
Through four independent criteria, it is concluded that the
P1 membrane fraction contains the GCAP1-modulated Ca2+-
inhibited ROS-GC1 transduction system and the system is
functionally and biochemically identical to the one linked
with the phototransduction machinery.
Cross-Linking Analysis ReVeals that GCAP1 and
ROS-GC1 Reside in Proximity in the Retinal P1 Fraction
To be physiologically relevant, GCAP1 and ROS-GC1
must reside in proximity. This was determined by cross-
linking studies. The noncleavable imidoester DMS was used
as a cross-linker. The reaction and analysis were carried out
as described in Experimental Procedures, and the results are
presented in Figure 6. Without the cross-linker, the ROS-
GC1 antibody identified only the ROS-GC1 monomer and
the GCAP1 antibody the GCAP1 monomer. In the presence
of the cross-linker, both GCAP1 and ROS-GC1 antibodies
identified a common immunoreactive band at 250 kDa
(indicated by a double-headed arrow). The size is that
expected for a ROS-GC1 dimer-GCAP1 complex. The band
was absent when the cross-linker was omitted (compare +
lanes vs - lanes in GCAP1 and ROS-GC1). The mobility
of the cross-linked complex suggests that the predominant
interaction between ROS-GC1 and GCAP1 occurs in their
dimeric forms. In reactions with the ROS-GC1 antibody, an
immunoreactive band at 120 kDa is seen and corresponds
to the ROS-GC1 monomer (Figure 6, both lanes, ROS-GC1
panel). In reactions with the GCAP1 antibody, an immu-
noreactive band corresponding to the GCAP1 monomer is
detected (Figure 6, both lanes, GCAP1 panel). Several
additional bands are observed with the GCAP1 antibody
probe in the presence of the cross-linker (Figure 6, + lane,
GCAP1 panel), indicating that this protein may interact with
several proteins other than ROS-GC1 in the retinal P1 layer.
The results show that ROS-GC1 and GCAP1 reside in
proximity in the retinal P1 fraction.
ROS-GC1 and GCAP1 Colocalize in Cone Synaptic
Termini
To determine if ROS-GC1 and GCAP1 are localized in
the outer plexiform layer, which is concentrated in the P1
fraction, immunolocalization of the two proteins was carried
out on serial cryosections of the retina. Staining for ROS-
GC1 was intense in both the rod and cone outer segments
(Figure 7B). This is in agreement with the conclusion that
the cyclase is expressed in both photoreceptor outer segments
based on biochemical and genetic analyses (4, 5, 43-45).
Staining was also observed in the inner segments, particularly
those of cones. When Triton X-100 was excluded from the
incubation medium, staining for the outer segment was still
present; in addition, staining was also observed in the OPL
and a weaker staining in the inner plexiform layer (IPL,
Figure 7C). Under both conditions (with and without
detergent), preadsorption of the antibody with the antigen
eliminated the staining (data not shown).
FIGURE 5: Presence of GCAP1 in the membranes of the P1 fraction
and immunological analyses with the GCAP1-specific antibody.
(A) Specificity of the GCAP1 antibody. Bacterially expressed and
purified GCAP1 (rGCAP1), GCAP2 expressed in insect cells and
purified (rGCAP2), and membranes from retina (RETINA) were
electrophoresed and analyzed by Western blotting. (B) GCAP1
expression in the P1 fraction. Membranes of the P1 fraction were
isolated and analyzed by Western blotting as described in Experi-
mental Procedures. Fifty micrograms of the membrane protein was
loaded in the PR-OS and P1 lanes; 0.5 íg of recombinant GCAP1
(rGCAP1) served as a control. Molecular size markers are given.
FIGURE 6: ROS-GC1 and GCAP1 are in proximity in the P1
fraction. The gel shows a cross-linking analysis. Membranes of the
P1 fraction were isolated and incubated in the presence or absence
of added GCAP1 (1 íM) with or without the cross-linker DMS.
Cross-linking was carried out as described in Experimental
Procedures. The reaction was terminated by boiling in SDS-PAGE
loading buffer. Duplicate samples were electrophoresed on SDS-
6% polyacrylamide gels and analyzed by Western blotting with
ROS-GC1 or GCAP1 antibody. Similar results were obtained in
the presence or absence of added GCAP1, except that the band
intensities were enhanced in the presence of GCAP1. The results,
with added GCAP1, are presented in the respective panels; a 100
íg equivalent of membrane protein was loaded in each lane. A
common band, corresponding to 250 kDa, is observed with both
antibodies in the presence of the cross-linker (+ lanes) and is
denoted with a double-headed arrow. Only the monomers of
GCAP1 and ROS-GC1 are observed in the absence of the cross-
linker (- lanes). Molecular size markers are given.
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Positive staining for GCAP1 is observed in the outer
segments, inner segments, outer nuclear layer, and outer
plexiform layer (Figure 7D). In the outer and inner segment
layers, predominant staining was observed in the cone inner
and outer segments. These observations are consistent with
those from earlier studies (10, 11, 30-33). In the OPL,
staining was in large structures, from which axons were
ascending through the ONL to the inner segments. These
are likely cone synaptic termini.
To determine which structures within the OPL are stained,
the sections were doubly labeled with the antibodies against
GCAP1 or ROS-GC1 and SV2, a synaptic vesicle protein
that strongly stains photoreceptor termini (46). At higher
magnification, colocalization of ROS-GC1 (in green) and
SV2 (in red) is seen throughout the OPL, suggesting that
ROS-GC1 is expressed in photoreceptor termini (Figure 7E).
Some photoreceptor termini are indicated with arrows. The
colocalization of GCAP1 with SV2 is presented in Figure
7F. Staining for GCAP1 is strong in the OPL, and it
colocalizes with SV2, confirming that the GCAP1-positive
structures in the OPL are cone synaptic termini. Because
both ROS-GC1 and GCAP1 are localized to cone synaptic
FIGURE 7: ROS-GC1 and GCAP1 are colocalized in cone synaptic termini. Radial cryosections of bovine retina were immunostained for
ROS-GC1 and GCAP1. (A) Differential interference contrast (DIC) image of a retinal section showing the retinal layers. (B) Distribution
of ROS-GC1 as revealed by staining with the standard protocol. Staining is strong in rod and cone outer segments but is also present in
other cells in the INL and GCL. (C) Distribution of ROS-GC1 as revealed by omitting Triton X-100. Staining is more ubiquitous, and is
strong in the OPL. (D) Distribution of GCAP. Staining is strong in cone outer and inner segments and in the OPL. (E) Double staining for
ROS-GC1 and SV2 (in the absence of the detergent Triton X-100). Certain OPL structures stained for SV2 (red) are also stained for
ROS-GC1 (green); these appear orange-yellow in the MERGE panel. Some are denoted with arrows. The lack of total colocalization may
be due to limited penetration in the ROS-GC1 staining. (F) Double staining for GCAP1 and SV2. All GCAP1-positive (green) structures
in the OPL are also stained for SV2 (red) and appear orange-yellow in the MERGE panel. Some are denoted with arrows. Abbreviations:
OS, outer segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL,
ganglion cell layer. The boundaries of the different layers have been denoted with dashed lines.
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termini, results from immunostaining, together with bio-
chemical and cross-linking analyses, establish that these two
proteins are coexpressed not only in the cone outer segment
but also in the cone synaptic terminus, which is presynaptic
to the bipolar neurons.
DISCUSSION
To date, the physiologically relevant GCAP-mediated Ca2+
signaling has only been found in photoreceptor outer
segments. There it regulates the activity of the membrane-
bound guanylate cyclase ROS-GC1 and is a critical part of
a negative feedback loop that defines the recovery of a
photoreceptor’s light response. GCAPs sense changes in the
Ca2+ concentration and undergo a conformational change.
The change triggers activation of ROS-GC1 at low Ca2+
concentrations and inhibition of ROS-GC1 at high Ca2+
concentrations. This study provides comprehensive bio-
chemical and immunological evidence to show that GCAP1-
mediated Ca2+ signaling is also present in the presynaptic
region of the photoreceptor cells, and it colocalizes with
ROS-GC1.
In a recent report, Duda et al. (34) showed that ROS-GC1
with its Ca2+ sensor S100â is present in the photoreceptor-
bipolar synaptic layer, and in this layer, Ca2+ stimulates ROS-
GC1. It is, thus, concluded that the outer synaptic layer is
an area of extreme sensitivity to Ca2+ waves and that the
waves are sensed by either GCAP1 or S100â, which, in turn,
stimulates or inhibits ROS-GC1. The study presented here
establishes the presynaptic localization of the GCAP1/ROS-
GC1 transduction system. Whether the S100â/ROS-GC1
transduction system is presynaptic, postsynaptic, or both
remains to be investigated. In addition to GCAP1 and S100â,
ROS-GC1 is also modulated by GCAP2 (reviewed in refs 1
and 2). The current evidence indicates that GCAP2 is also
present in the retinal synaptic layers (30-32), creating the
possibility that the GCAP2/ROS-GC1 system may also be
functional. This possibility also remains to be investigated.
At the moment, one can only speculate about how the
GCAP1/ROS-GC1 system is linked to other signaling
components in the presynaptic region of photoreceptors. A
possible target of cyclic GMP could be a CNG channel in
synaptic termini of cones (47, 48). Activation of these
channels triggers release of glutamate from the terminus. The
GCAP1/ROS-GC1 system could provide a Ca2+-dependent
negative feedback control of CNG channels. When the Ca2+
influx via voltage-dependent Ca2+ channels stops (for
example, during hyperpolarization), the free Ca2+ concentra-
tion in synaptic termini would transiently decrease and in
turn activate the GCAP1/ROS-GC1 system. It has been
recently shown that Ca2+ levels fluctuate over a 10-fold range
in photoreceptor synapses and reach values as low as 50 nM
(reviewed in ref 49), where the GCAP1/ROS-GC1 system
is, indeed, most effective. An increase in the level of cyclic
GMP would open the CNG channels, and an influx of Ca2+
would dampen the GCAP1/ROS-GC1 system. The CNG
channels in cone synaptic termini appear to be influenced
also by nitric oxide, which can activate the soluble form of
a guanylate cyclase present in inner segments of photore-
ceptors (50). Thus, the complexity of cyclic GMP signaling
in synaptic regions points to several spatially and temporarily
restricted events and needs to be worked out in more detail.
Recent investigations have documented the presence of a
Ca2+-modulated membrane guanylate cyclase transduction
system in three neuronal systems besides visual transduc-
tion: the pinealocytes, the cilia of the olfactory neuroepi-
thelium, and the olfactory bulb (35-37). Like the photore-
ceptors, the pineal gland is modulated by light. The ciliated
apical border of sensory neurons located in the epithelial layer
is the site of odorant transduction. And, the olfactory bulb
is the second neural compartment where the odorant signal
is processed and is then transmitted to the olfactory cortex
for smell perception. Ca2+-regulated membrane guanylate
cyclase resides in all three neural systems (35-37). One class
of the pinealocytes contains the GCAP1/ROS-GC1 trans-
duction system, and the second class contains the S100â/
ROS-GC1 transduction system (35). The olfactory cilia
contain the neurocalcin/ONE-GC [also known as GC-D (51)]
transduction system (36), and the olfactory bulb contains the
GCAP1/ROS-GC1 transduction system (37). Thus, native
functional expression of ROS-GC1 is not restricted to outer
segments of photoreceptor cells, and its expression may be
a common feature of neurons linked with sensory perception.
Its regulatory features are rather complex and depend on the
specific cellular or subcellular localization.
The different modulatory features of ROS-GC1 are pos-
sible through the presence of regulatory and/or target regions
in distant domains of the protein. Like other members of
the membrane guanylate cyclase family, ROS-GC1 is a
modular protein with the following common topography. A
single helical transmembrane domain divides the protein into
two portions. The N-terminus consists of an extracellular
domain or intradiscal domain when present in PR-OS. The
intracellular region is comprised of a juxtamembrane domain,
a kinase homology domain, a dimerization domain, and a
core catalytic domain. The guanylate cyclase family is
subdivided into two subfamilies: the peptide hormone
receptor and the Ca2+-modulated ROS-GC (reviewed in ref
1). The extracellular domain of the peptide hormone receptor
subfamily contains the receptor domain. To date, in the ROS-
GC subfamily, neither a ligand for nor the functional
relevance of this domain has been found. As a functional
unit, it is believed that all membrane guanylate cyclases exist
as homodimers (reviewed in ref 1). The ROS-GC subfamily
contains an added segment at its C-terminus, which is not
shared with the peptide receptor subfamily (reviewed in refs
1 and 2). This has been termed the C-terminal extension. A
recent study has shown that the C-terminal extension is the
site of the S100â-modulated domain in ROS-GC1, and this
domain regulates the catalytic activity of the cyclase (34).
This domain has been mapped to two small regions: one
region comprises amino acids (aa) G962-N981 and the other
aa I1030-Q1041. The GCAP1-modulated domain resides
at two regions, M445-L456 and L503-I522, in the jux-
tamembrane domain (25). The domain is physiologically
linked with the GCAP1-modulated activity, because a point
mutation in this domain causes Leber’s congenital amaurosis
and loss of GCAP1-dependent ROS-GC1 regulation (44).
Two other GCAP1 binding regions have also been reported,
and they also reside at the N-terminal side of the catalytic
domain; however, these regions have not been physiologi-
cally linked with GCAP1 regulation (25). Thus, the GCAP1-
regulated module resides at the N-terminal side of the
catalytic module and the S100â-regulated module at its
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C-terminal side, and the two modules independently regulate
the catalytic module. These findings allow the formation of
a new topographic model of ROS-GC1 transduction (Figure
8). In this model, the catalytic module of ROS-GC1 at its
opposite ends is flanked by GCAP1 and S100â modules.
GCAP1 senses the Ca2+ impulse and inhibits the catalytic
module; S100â senses the impulse and stimulates the
catalytic module. In this manner, ROS-GC1 acts as a bimodal
Ca2+ signal transduction switch in sensory neurons. The
model defines reciprocal regulation of ROS-GC1 by Ca2+
in biochemical terms. Finally, the location of the high Ca2+-
regulated domain in the C-terminal extension may constitute
a signature feature of the ROS-GC subfamily of membrane
guanylate cyclases.
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